Navigation Links
Henry Ford Hospital study: A MRSA strain linked to high death rates
Date:10/31/2009

A strain of MRSA that causes bloodstream infections is five times more lethal than other strains and has shown to have some resistance to the potent antibiotic drug vancomycin used to treat MRSA, according to a Henry Ford Hospital study.

The study found that 50 percent of the patients infected with the strain died within 30 days compared to 11 percent of patients infected with other MRSA strains.

The average 30-day mortality rate for MRSA bloodstream infections ranges from 10 percent to 30 percent.

Researchers say the strain USA600 contains unique characteristics that may be linked to the high mortality rate. But they say it is unclear whether other factors like the patients' older age, diseases or the spread of infection contributed to the poor outcomes collectively or with other factors. The average age of patients with the USA600 strain was 64; the average age of patients with other MRSA strains was 52.

The study is being presented at the 47th annual meeting of the Infectious Diseases Society of America Oct. 29-Nov.1 in Philadelphia.

"While many MRSA strains are associated with poor outcomes, the USA600 strain has shown to be more lethal and cause high mortality rates," says Carol Moore, PharmD., a research investigator in Henry Ford's Division of Infectious Diseases and lead author of the study.

"In light of the potential for the spread of this virulent and resistant strain and its associated mortality, it is essential that more effort be directed to better understanding this strain to develop measures for managing it."

MRSA, or Methicillin-resistant Staphylococcus aureus, is a bacterium that is resistant to common antibiotics like penicillin. It can cause skin, bloodstream and surgical wound infections and pneumonia. The majority of infections occur among patients in hospitals or other health care settings, though a growing number of infections are being acquired by otherwise healthy people outside those settings.

MRSA strains can be resistant to many drugs, though they are typically susceptible to the antibiotic vancomycin. MRSA infections are often treated with vancomycin administered intravenously. The USA600 strain in this study was shown to be more resistant to vancomycin.


'/>"/>

Contact: David Olejarz
Dolejar1@hfhs.org
313-303-0606
Henry Ford Health System
Source:Eurekalert

Related medicine news :

1. Grosse Pointes Cottage Hospital Joins Henry Ford Health System
2. CNS Response, Inc. Names Henry T. Harbin, MD to Board of Directors
3. Fund-Raiser for Henry Ford Hospitals Stroke Program
4. Program for Stroke Survivors and Friends Hosted by Henry Ford Hospital
5. Repligen Elects Earl Henry, M.D. to the Board of Directors
6. Michigan Quality Council (MQC) Names Henry Ford Health System 2007 State Quality Award Recipient
7. AAPD to Present 2008 Henry B. Betts Award to International Human Rights Disability Advocate Eric Rosenthal
8. Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Henry Schein Medical Systems MicroMD(R) EMR 5.0
9. Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer
10. Henry Ford Hospital to study effectiveness of a new procedure that may help emphysema suffers
11. Stella Mora Henry to Present The Eldercare Handbook at Aging in America Joint Conference of National Council on Aging & The American Society on Aging March 27-29
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2020)... ... February 13, 2020 , ... A January 24 article ... will be discussing in 2020. It also reports on a well-documented dramatic and ongoing ... Jazayeri says that his patients are increasingly knowledgeable and are asking about a number ...
(Date:2/11/2020)... ... February 11, 2020 , ... Soterius, Inc., a ... its move to a new, significantly larger business premises in Lawrenceville, NJ. The ... in the development of digital technology platforms. , “As our customer base and ...
(Date:2/11/2020)... ST. PETERSBURG, Fla. (PRWEB) , ... February 11, ... ... network of full-service dental laboratories across North America, is pleased to announce a ... over six years, Dental Services Group® (DSG) has generously donated to the ...
(Date:2/10/2020)... PASADENA, Calif. (PRWEB) , ... February 10, 2020 , ... ... experience sensitivity in their teeth in certain situations. The answer is that – not ... or harsh forces – pain and sensitivity serve as an alert to potential damage ...
(Date:2/10/2020)... ... February 10, 2020 , ... Buxton is pleased to ... division. In this role, Nikki will support Buxton’s current and prospective clients by ... development. , “The healthcare industry is increasingly understanding the importance of consumer-centric ...
Breaking Medicine News(10 mins):
(Date:2/14/2020)... CHURCH, Va. (PRWEB) , ... February 14, 2020 ... ... of Pharmaceuticals, Biologics and Medical Devices, An FDAnews Webinar , Tuesday, Feb. 25, ... on importation issues with pharmaceuticals and medical devices? If one does not know ...
(Date:2/13/2020)... ... February 13, 2020 , ... The global market for clinical laboratory services is ... of $93.9 billion in 2010, according to a new report from Kalorama Information. Kalorama ... this market is driven by an aging population and a growing incidence of chronic ...
(Date:2/13/2020)... ... February 13, 2020 , ... Worldwide Business with ... Skincare Founder and Leukemia Lymphoma Society's Woman of The Year Candidate Carmen ... , Latina-owned and founded in San Francisco, Borbón Skincare is a premium skincare ...
Breaking Medicine Technology: